Mostra i principali dati dell'item
Effectiveness of oral vitamin D supplementation in lessening disease severity among patients with psoriasis: A systematic review and meta-analysis of randomized controlled trials
| dc.creator | Theodoridis X., Grammatikopoulou M.G., Stamouli E.-M., Talimtzi P., Pagkalidou E., Zafiriou E., Haidich A.-B., Bogdanos D.P. | en |
| dc.date.accessioned | 2023-01-31T10:07:53Z | |
| dc.date.available | 2023-01-31T10:07:53Z | |
| dc.date.issued | 2021 | |
| dc.identifier | 10.1016/j.nut.2020.111024 | |
| dc.identifier.issn | 08999007 | |
| dc.identifier.uri | http://hdl.handle.net/11615/79680 | |
| dc.description.abstract | Objective: Many treatment modalities have been used to manage psoriasis; however, there is, to our knowledge, no pooled estimate for the effectiveness of oral vitamin D supplements in patients with psoriasis. Hence, the aim of the present study was to systematically review and meta-analyze the efficacy of oral vitamin D supplementation in lessening disease severity of patients with psoriasis. Methods: A systematic literature review was performed on the electronic databases PubMed, Embase, and Cochrane Central and the gray literature for retrieving randomized controlled trials comparing oral vitamin D supplementation with placebo. The primary outcome was the change of Psoriasis Area and Severity Index (PASI) score. We used the random effects model for synthesizing the evidence. Results: Of the total 5018 search results, 4 studies were included in the qualitative and 3 studies in quantitative analysis. Vitamin D supplementation was effective in ameliorating the PASI score after 6 mo of intervention (mean difference [MD] = –0.92, 95% confidence interval [CI] = –1.72 to –0.11). However, after the Hartung-Knapp adjustment, the results became non-significant (MD = –0.92, 95% CI = –2.21 to 0.38). Conclusions: A favorable effect of oral vitamin D supplementation in patients with psoriasis could not be verified. More randomized controlled trials with larger sample sizes are needed to produce robust results. © 2020 Elsevier Inc. | en |
| dc.language.iso | en | en |
| dc.source | Nutrition | en |
| dc.source.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85095876282&doi=10.1016%2fj.nut.2020.111024&partnerID=40&md5=228c3b4ab714bd8cd243f19415e2c38d | |
| dc.subject | colecalciferol | en |
| dc.subject | ergocalciferol | en |
| dc.subject | placebo | en |
| dc.subject | vitamin D | en |
| dc.subject | vitamin D | en |
| dc.subject | disease severity | en |
| dc.subject | drug efficacy | en |
| dc.subject | human | en |
| dc.subject | meta analysis | en |
| dc.subject | patient compliance | en |
| dc.subject | priority journal | en |
| dc.subject | psoriasis | en |
| dc.subject | Psoriasis Area and Severity Index | en |
| dc.subject | randomized controlled trial (topic) | en |
| dc.subject | Review | en |
| dc.subject | systematic review | en |
| dc.subject | treatment outcome | en |
| dc.subject | unspecified side effect | en |
| dc.subject | vitamin supplementation | en |
| dc.subject | dietary supplement | en |
| dc.subject | severity of illness index | en |
| dc.subject | Dietary Supplements | en |
| dc.subject | Humans | en |
| dc.subject | Psoriasis | en |
| dc.subject | Randomized Controlled Trials as Topic | en |
| dc.subject | Severity of Illness Index | en |
| dc.subject | Vitamin D | en |
| dc.subject | Elsevier Inc. | en |
| dc.title | Effectiveness of oral vitamin D supplementation in lessening disease severity among patients with psoriasis: A systematic review and meta-analysis of randomized controlled trials | en |
| dc.type | other | en |
Files in questo item
| Files | Dimensione | Formato | Mostra |
|---|---|---|---|
|
Nessun files in questo item. |
|||